Eustachian Tube Dysfunction
Conditions
Brief summary
Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective
Detailed description
forty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I or group II. the group enroled 20 seniors. both groups wil take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.
Interventions
twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.
twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.
Sponsors
Study design
Eligibility
Inclusion criteria
* Eustachian Tube Dysfunction (chronic obstructive form) * unilateral ear affetion * senior patients * chronci affection more than 3 months
Exclusion criteria
* obesity * cardiac probelms repsiratory problems
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Eustachian Tube Dysfunction Questionnaire | it will be measured after 2 weeks | it will be used to asses symptoms of Eustachian Tube Dysfunction |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| diastolic blood pressure | it will be measured after 2 weeks | it will be measured manually by manual sphygmomanometer |
| respiratory rate | it will be measured after 2 weeks | it will assess breath number per minute |
| pulse rate | it will be measured after 2 weeks | it will assess pulse number per minute from radial artery |
| patient health questionnaire | it will be measured after 2 weeks | it will assess depression in patients |
| systolic blood pressure | it will be measured after 2 weeks | it will be measured manually by manual sphygmomanometer |
| perceived stress scale | it will be measured after 2 weeks | it will assess stress in patients |
| short form 36 questionnaire | it will be measured after 2 weeks | it will assess quality of life in patients |
| profile of mood satus | it will be measured after 2 weeks | it will assess mood in patients |
| percenatge of tympanometry (type C) | it will be measured after 2 weeks | it will assess percenatge of type c tympanometry |
| state trait anxiety inventory | it will be measured after 2 weeks | it will assess trait anxiety in patients |
Countries
Egypt